Tag | Content |
---|
EnhancerAtlas ID | HS139-10645 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr11:110227590-110228690 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Arid3b | MA0601.1 | chr11:110228525-110228536 | GTAATTAATAT | - | 6.02 | Crx | MA0467.1 | chr11:110227728-110227739 | AAGGGGATTAG | + | 6.32 | IRF1 | MA0050.2 | chr11:110228438-110228459 | TCTTTCTTTCTCTTTTTTCTT | + | 6.13 | IRF1 | MA0050.2 | chr11:110228428-110228449 | TTTTACTTTTTCTTTCTTTCT | + | 6.66 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_68357 | chr11:110219158-110234598 | TC32 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I110354 | chr11 | 110225223 | 110229415 |
|
Enhancer Sequence | TTCAGCAGTG ACGTAGGAAA GGTCTGTATG CCTGGGAATG TGGAGATCTA GGTTTTAATC 60 TAAGATCTGA GTTCATTGTC CTGTATTTAT CTAAGGCCAG TCACCCTCTT TCGGCTGCTA 120 TTGCTTCATG TTTAAAACAA GGGGATTAGA TGAAATGATT GGCAAAGTCC CTTGCAGCAT 180 TAATAGCCTA TGAGTCTATA AAATTTTAGA AACAGACATA ATTCAGAAGG ATATAATTTT 240 AAATCAATTT GTGTCACAAC AGTAATAATA AACATAGTGG CTCTAAGCAA GTAACAGACT 300 GAGAGAAAGA AACTATGAAT TAGATAAGTT TGACTAGATA AGGTCTAAGT TCTTTCCAAC 360 TTTGAAATCC ATGATCACAT ATTACAACAC TGTAATTTTA TAGTAGTTTG TAGGGTTTCA 420 AAGAACTTTC ATTCGATTTA TCCTCTCTGA TCCTCACAGG GACAATATGA AGCGGTGAGA 480 AGAGTTGTTT TATCCACACT CTACAAATGA AGGAACTAAA GATTAAGTGG GTGGCATTGG 540 GTCACTTGGC TAGTTGGGGA CACAGCTGGG ACAGCAAGGC TTTCTGACTC ACACCCTGCC 600 CTCTATGCCA TAGCATTCCT GGGCTCAATA AACAGTAACT GTGAAAGAAG GTCGCCTCAC 660 ACAAAACTAC ATTTTATTCT AGTTTGACAG ATGAGTAATC CTCAGTGATA AATTCCTTTT 720 CTGAAAAGTC TCAAAGTCCC TTGGGCAGTT TTGAGTCATT TGTAATGTCA AAAAGTTTAG 780 GACAGACAGT ATTTGCAACT TTCCTCAAAT CCAAAAATCA GAAAAGCTGG GGAGAGGTTT 840 TTACTTTTTC TTTCTTTCTC TTTTTTCTTT TTTTTTTGTA GACTAAGTCA CAAGAAGGAA 900 GGGTTTTACT TTTTCTTTTC AACTTAAAAA AGAGAGTAAT TAATATCCTA AATTCTCTTT 960 GTCCTAAGAC ACCTTTCCTA AGAACCATGA GCTTTTAGCT AAGTATGGAG GACGTTTAGT 1020 AGCCATGACT AAGCAACTCA TCTTTCAGTT ACAGAATAGC CTATGTTGGC CGGGCGCAGT 1080 GGCTCACCCT CCGTAATCTC 1100
|